Alpine Immune Sciences, Inc.
Alpine Immune Sciences, Inc. (ALPN) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
alpn · stock forecast · 15 analysts (3M) · FMP · updated Apr 20, 2025
Analyst Rating & Consensus
Based on 15 Wall Street analysts in the past 3 months
Buy
15 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$65.00
Consensus
$55.00
-15.3% upside
Low
$44.00
Median: $55 · Last Close: $64.97
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$55.00
-15.3% upside
High Target
$65
0.0%
Low Target
$44
-32.3%
Current Price
$64.97
as of today
Based on analyst price targets, the ALPN stock price prediction for the next 12 months ranges from $44 to $65. The consensus ALPN price forecast of $55.00 implies -15.3% upside from the current price of $64.97.
Short-Term Price Prediction
BullAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $64.87 | ↓ 0.16% |
1-day model range: $63.56–$66.17. Peak: $66.17 (-0.16%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $107 | +65.3% |
| 2028 | $150 | +130.1% |
| 2029 | $185 | +184.2% |
| 2030 | $211 | +224.3% |
| 2031 | — | +251.8% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ALPN · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2024-05-16 | Wedbush | Maintains | Neutral→Neutral |
| 2024-04-16 | TD Cowen | Downgrade ↓ | Buy→Hold |
| 2024-04-12 | Leerink Partners | Downgrade ↓ | Outperform→Market Perform |
| 2024-04-11 | Morgan Stanley | Downgrade ↓ | Overweight→Equal Weight |
| 2024-04-11 | Wedbush | Downgrade ↓ | Outperform→Neutral |
| 2024-04-11 | Wolfe Research | Downgrade ↓ | Outperform→Peer Perform |
| 2024-04-11 | RBC Capital | Downgrade ↓ | Outperform→Sector Perform |
| 2024-03-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-03-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-03-19 | Wedbush | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Alpine Immune Sciences, Inc. (ALPN) stock. Of the recent 49 rating actions, 3 were upgrades and 6 were downgrades. 15 analysts currently cover ALPN.
Analyst Recommendation Trends
ALPN analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 4 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$15M
↑ 71.8% YoY
Revenue Next Year
$15M
↓ 1.5% YoY
EPS This Year
$-1.65
EPS Next Year
$-1.88
↑ 14.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast ALPN EPS of $-1.65 for the current fiscal year, based on estimates from 4 analysts. The ALPN revenue forecast is $15M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The ALPN stock forecast is supported by two independent data sources: analyst consensus ratings from 15 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ALPN price target is $55.00 (-15.3% upside), with an analyst consensus of Buy.
The ALPN short-term stock prediction for tomorrow is $64.87 (-0.16%). The ALPN stock price prediction for 2027 estimates an average of $107. The ALPN stock prediction for 2030 projects a range of $178–$244.
Alpine Immune Sciences, Inc. trades on NASDAQ under the ticker ALPN. The ALPN stock outlook for 2027 is broadly positive, supported by a Buy consensus among 60% of covering analysts.
Frequently asked questions
ALPN forecast · 8 questionsAccording to 15 Wall Street analysts, the average 12-month ALPN price target is $55.00, with a high forecast of $65.00 and a low of $44.00. The median price target is shown in the chart above when available. This implies -15.3% potential upside from the current price of $64.97.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.